Exhaled breath condensate eicosanoids and sputum eosinophils in asthmatic children: A pilot study

Pediatric Allergy and Immunology

Volumn 15, Issue 1, 2004, Pages 26-31

  Bodini, A ^a   Peroni, Diego ^a,e   Vicentini, L ^a   Loiacono, A ^b   Baraldi, E ^d   Ghiro, L ^d   Corradi, M ^c   Alinovi, R ^c   Boner, A L ^a   Piacentini, G L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Istituto Pio XII   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e Policlinico Universitario gB Rossi   (Italy)

Author keywords

8 isoprostane; Airway inflammation; Exhaled breath condensate; Leukotriene; Sputum eosinophil

Indexed keywords

8 ISOPROSTANE; HOUSE DUST ALLERGEN; ICOSANOID; ISOPROSTANE; LEUKOTRIENE B4; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ASTHMA; AVOIDANCE BEHAVIOR; CLINICAL ARTICLE; DERMATOPHAGOIDES; EOSINOPHIL; EXHALED BREATH CONDENSATE; EXPIRED AIR; FEMALE; HUMAN; INFLAMMATION; ITALY; LEUKOCYTE COUNT; LUNG FUNCTION; MALE; NEUTROPHIL; NON INVASIVE MEASUREMENT; PILOT STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIZATION; SPUTUM EOSINOPHIL; SPUTUM EXAMINATION;

ADOLESCENT; ALTITUDE; ASTHMA; BREATH TESTS; CHILD; CYSTEINE; EICOSANOIDS; EOSINOPHILS; FEMALE; HUMANS; LEUKOTRIENE B4; LEUKOTRIENES; MALE; PILOT PROJECTS; PROSTAGLANDINS A; PYROGLYPHIDAE; SPUTUM;

EID: 12144286455     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0905-6157.2003.00097.x     Document Type: Article

References (32)

1. LEFF AR. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Respir Crit Care Med 2000: 161: S125-32.
2. GARCIA-MARCOS L, SCHUSTER A. New perspectives for asthma treatment: anti-leukotriene drugs. Pediatr Allergy Immunol 1999: 10: 77-88.
3. BISGAARD H. Leukotriene modifiers in pediatric asthma management. Pediatrics 2001: 107: 381-90.
4. O'SULLIVAN S, ROQUET A, DAHLÉN B, et al. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998: 28: 1332-9.
5. MACFARLANE AJ, DWORSKI R, SHELLER JR, et al. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatic. Am J Respir Crit Care Med 2000: 161: 1553-8.
6. CHRISTIE PE, YNTEMA JL, TAGARI P, et al. Effect of altitude on urinary leukotriene (LT) E4 excretion and airway responsiveness to histamine in children with atopic asthma. Eur Respir J 1995: 8: 3:57-63.
7. GROOTENDORST DC, DAHLEN SE, VAN DEN BOS JW, et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy 2001: 31: 400-8.
8. JANSSEN LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001: 280: L1067-82.
9. DWORSKI R. Oxidant stress in asthma. Thorax 2000: 55(Suppl 2): S51-3.
10. WOOD LG, FITZGERALD DA, GIBSON PG, et al. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000: 35: 967-74.
11. DWORSKI R, MURRAY JJ, ROBERTS LJ II, et al. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med 1999: 160: 1947-51.
12. MONTUSCHI P, BARNES PJ. Exhaled leukotrienes and prostaglandines in asthma. J Allergy Clin Immunol 2002: 109: 615-20.
13. MONTUSCHI P, CORRADI M, CIABATTONI G, et al. Increased 8-isoprostane, a biomarker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999: 160: 216-20.
14. GIBSON PG, HENRY RL, THOMAS P. Noninvasive assesment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000: 16: 1008-15.
15. BARALDI E, CARRARO S, ALINOVI R, et al. Cystenil-leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbation. Thorax 2003: 58: 505-9.
16. MONTUSCHI P, RAGAZZONI E, VALENTE S, et al. Validation of leukotriene B4 measurements in exhaled breath condensate. Inflamm Res 2003: 52: 69-73.
17. American Thoracic Society. Recommendations for standardized procedures for the on-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999: 160: 2104-17.
18. VERVLOET D, PENAUD A, RAZZOUK H, et al. Altitude and house dust mites. J Allergy Clin Immunol 1982: 69: 290-6.
19. BONER AL, NIERO E, ANTOLINI I, et al. Pulmonary function and bronchial hyperreactivity in asthmatic children with house dust mite allergy during prolonged stay in the Italian Alps (Misurina, 1756 m). Ann Allergy 1985: 54: 42-5.
20. VAN VELZEN E, VAN DEN BOS JW, BENCKHUIJSEN JA, et al. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996: 51: 582-4.
21. PIACENTINI GL, MARTINATI L, MINGONI S, et al. Influence of allergen avoidance on the eosinophil phase of airway inflammation in children with allergic asthma. J Allergy Clin Immunol 1996: 97: 1079-84.
22. PIACENTINI GL, BODINI A, COSTELLA S, et al. Allergen avoidance is associated with a fall in exhaled nitric oxide in asthmatic children. J Allergy Clin Immunol 1999: 104:1323-4.
23. WILSON NM, JAMES A, UASUF C, et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001: 12: 125-32.
24. KHARITONOV SA, BARNES PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001: 163: 1693-722.
25. CSOMA Z, KHARITONOV SA, BALINT B, et al. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002: 166: 1345-9.
26. JUST J, FOURNIER L, MOMAS I, et al. Clinical significance of bronchoalveolar eosinophils in childhood asthma. J Allergy Clin Immunol 2001: 110: 24-5.
27. WARK PA, JOHNSTON SL, MORIC I, et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002: 19: 68-75.
28. DOUWES J, GIBSON P, PEKKANEN J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002: 57: 566-8.
29. BARBATO A, PANIZZOLO C, GHENO M, et al. Bronchoalveolar lavage in asthmatic children: evidence of neutrophil activation in mild-to-moderate persistent asthma. Pediatr Allergy Immunol 2001: 12: 73-7.
30. MARGUET C, DEAN TP, BASUYAU JP, WARNER JO. Eosinophil cationic protein and interleukin 8 levels in bronchial lavage fluids from children with asthma and infantile wheeze. Pediatr Allergy Immunol 2001: 12: 27-33.
31. LEE E, ROBERTSON T, SMITH J, KLIFEATHER S. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med 2000: 161: 1881-6.
32. BARRETO M, VILLA MP, MARTELLA S, et al. Exhaled nitric oxide in asthmatic and non-asthmatic children: influence of type of allergen sensitisation and exposure to tobacco smoke. Pediatr Allergy Immunol 2001: 12: 247-56.